Guadagnuolo V, Papayannidis C, Iacobucci I, et al. SIRPB1: biomarker of response to 5-azacitidine treatment in MDS and AML patients. EHA 2017, abstract E1201.
Behandeling met emicizumab bij ernstige hemofilie alleen in basispakket na prijsdaling
feb 2020 | Benigne hematologie